Polygenic scores from the MiR137 pathway explain variability in cognitive performance in patients with schizophrenia and controls.
-
1
The Cognitive Genetics & Cognitive Therapy Group, Depts. of Psychology and Biochemistry, National University of Ireland Galway, Ireland
-
2
Neuropsychiatric Genetics Research Group, Department of Psychiatry, Institute of Molecular Medicine, Trinity College Dublin, Ireland
Introduction
Genome-wide association studies have identified rs1622579, a common variant located within an intronic region of MiR137, as a risk variant for schizophrenia. MiR137 has a hypothesized role in neural cell proliferation, migration and maturation. Cognitively, this variant is associated with deficits in verbal episodic memory, and altered fronto-amygdala connectivity. As MiR137 interacts with several other genome wide associated variants (e.g. ZNF804A, TCF4, CACNA1C, CSMD1 and WBP1L), we tested whether these cognitive effects were associated with polygenic risk in a set of identified downstream targets of MiR137.
Methodology
Polygene scores were calculated by (1) selecting all identified downstream genetic targets of MiR137 (Hill et al., 2014); (2) selecting risk SNPs within each of these genes based on risk estimates from the Psychiatric Genomics Consortium (Ripke et al., 2011), and (3) ascribing a polygenic risk score to each participant based on the total number of risk alleles they carried. To define risk, we used 3 arbitrary p-value thresholds (p < 10-5, p < 0.05, and p < 0.5) from the PGC1 case-control analysis. To estimate these polygene effects on cognitive deficits associated with SZ (IQ, episodic and working memory, attention control, and theory of mind) linear regression analyses was performed, with age and gender entered as variables of no interest. We carried out three separate analyses: all cases and controls (n=586), patients with a broad diagnosis of psychosis including non-schizophrenia psychosis (n=489) and patients with schizophrenia and schizoaffective disorder (n=379).
Results
MiR137 polygenic risk scores were significantly higher in the broad and narrow diagnosis groups compared to the controls (F(2,1081) =5.52, p<0.01). Poorer performance on measures of IQ, memory, and attention were each found to be associated with higher MiR137 polygene scores thresholded at p=0.05, including paired associated learning (p<0.001); faces, letter-number sequencing (LNS) sustained attention to reaction time (SART) (p<0.01); full-scale IQ, logical memory (LM) and spatial working memory (SWM) (p<0.05). The amount of variance explained on the measures varied between 1% and 2.6%
Discussion
These data support a modest but significant influence of this MiR137 'pathway' on cognition, across multiple measures of cognition. These widespread cognitive effects are consistent with MiR137’s previously described role in brain development. Greater variance was explained when all cases and controls were included, rather than considering narrow, broad, and controls separately. Extending on previous findings, MiR137's effects on cognition were significantly more apparent when considered in combination with the other risk variants with which it interacts rather than when the rs1622579 risk variant was considered in isolation.
References
Hill, M. J., Donocik, J. G., Nuamah, R. A., Mein, C. A., Sainz-Fuertes, R., & Bray, N. J. (2014). Transcriptional consequences of schizophrenia candidate miR-137 manipulation in human neural progenitor cells. Schizophr Res, 153(1-3), 225-230.
Ripke, S., Sanders, A., Kendler, K., Levinson, D., Sklar, P., & Holmans, P. (2011). Genome-wide association study identifies five new schizophrenia loci. Nature genetics, 43(10), 969-976.
Keywords:
miR137,
Cognition,
Schizophrenia,
polygene,
risk variant
Conference:
Neuroscience Ireland Young Neuroscientists Symposium 2014 , Dublin, Ireland, 20 Sep - 20 Sep, 2014.
Presentation Type:
Poster Presentation
Topic:
Early Career Neuroscience
Citation:
Cosgrove
D,
Morris
D,
Anney
R,
Hargreaves
A,
Genomics Consortium
P,
Gill
M,
Corvin
A and
Donohoe
G
(2014). Polygenic scores from the MiR137 pathway explain variability in cognitive performance in patients with schizophrenia and controls..
Front. Neurosci.
Conference Abstract:
Neuroscience Ireland Young Neuroscientists Symposium 2014 .
doi: 10.3389/conf.fnins.2014.87.00013
Copyright:
The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers.
They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.
The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.
Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.
For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.
Received:
10 Sep 2014;
Published Online:
10 Sep 2014.
*
Correspondence:
Miss. Donna Cosgrove, The Cognitive Genetics & Cognitive Therapy Group, Depts. of Psychology and Biochemistry, National University of Ireland Galway, Galway, Ireland, donna.cosgrove@gmail.com